Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Ugeskrift for Laeger
|
October 24, 2007
[Mammography screening--advantages and disadvantages]
Anne Helene Olsen, Walter Schwartz, Ilse M M Vejborg
Ugeskrift for Laeger
|
September 8, 2009
[Fine needle aspiration cytology of mammography screening]
Birte Engvad, Anne-Vibeke Laenkholm, Walter Schwartz, et al.
Ugeskrift for Laeger
|
September 5, 2008
[Overdiagnosis and overtreatment of breast cancer 2]
Jens Peter Garne, Elsebeth Lynge, Niels Thorndal Kroman, et al.
Journal of Medical Screening
|
December 11, 2014
Decline in breast cancer mortality: how much is attributable to screening?
Sisse Helle Njor, Walter Schwartz, Mogens Blichert-Toft, et al.
Journal of Medical Screening
|
July 14, 2007
Predicting the risk of a false-positive test for women following a mammography screening programme
Sisse Helle Njor, Anne Helene Olsen, Walter Schwartz, et al.
Clinical Epidemiology
|
June 18, 2020
Morbidity as a Predictor for Participation in the Danish National Mammography Screening Program: A Cross-Sectional Study
Jakob H Viuff, Ilse Vejborg, Walter Schwartz, et al.
BMC Cancer
|
October 11, 2013
Mammographic density in birth cohorts of Danish women: a longitudinal study
Sophie Sell Hellmann, Elsebeth Lynge, Walter Schwartz, et al.
Ugeskrift for Laeger
|
June 12, 2008
[Overdiagnosis and overtreatment of breast cancer]
Jens Peter Garne, Elsebeth Lynge, Ilse Vejborg, et al.
Menopause (New York, N.Y.)
|
August 24, 2010
Type of hormone therapy and risk of misclassification at mammography screening
Sisse H Njor, Jesper Hallas, Walter Schwartz, et al.
International Journal of Cancer
|
January 10, 2009
Minimizing misclassification of hormone users at mammography screening
Sisse Helle Njor, Anette Tønnes Pedersen, Walter Schwartz, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Ugeskrift for Laeger
|
October 24, 2007
[Mammography screening--advantages and disadvantages]
Anne Helene Olsen, Walter Schwartz, Ilse M M Vejborg
Ugeskrift for Laeger
|
September 8, 2009
[Fine needle aspiration cytology of mammography screening]
Birte Engvad, Anne-Vibeke Laenkholm, Walter Schwartz, et al.
Ugeskrift for Laeger
|
September 5, 2008
[Overdiagnosis and overtreatment of breast cancer 2]
Jens Peter Garne, Elsebeth Lynge, Niels Thorndal Kroman, et al.
Journal of Medical Screening
|
December 11, 2014
Decline in breast cancer mortality: how much is attributable to screening?
Sisse Helle Njor, Walter Schwartz, Mogens Blichert-Toft, et al.
Journal of Medical Screening
|
July 14, 2007
Predicting the risk of a false-positive test for women following a mammography screening programme
Sisse Helle Njor, Anne Helene Olsen, Walter Schwartz, et al.
Clinical Epidemiology
|
June 18, 2020
Morbidity as a Predictor for Participation in the Danish National Mammography Screening Program: A Cross-Sectional Study
Jakob H Viuff, Ilse Vejborg, Walter Schwartz, et al.
BMC Cancer
|
October 11, 2013
Mammographic density in birth cohorts of Danish women: a longitudinal study
Sophie Sell Hellmann, Elsebeth Lynge, Walter Schwartz, et al.
Ugeskrift for Laeger
|
June 12, 2008
[Overdiagnosis and overtreatment of breast cancer]
Jens Peter Garne, Elsebeth Lynge, Ilse Vejborg, et al.
Menopause (New York, N.Y.)
|
August 24, 2010
Type of hormone therapy and risk of misclassification at mammography screening
Sisse H Njor, Jesper Hallas, Walter Schwartz, et al.
International Journal of Cancer
|
January 10, 2009
Minimizing misclassification of hormone users at mammography screening
Sisse Helle Njor, Anette Tønnes Pedersen, Walter Schwartz, et al.
Page
of 3